Israelitisches Krankenhaus Hamburg
- Address
- Orchideenstieg 14, Alsterdorf, 22297 Hamburg, Germany
Israelitisches Krankenhaus Hamburg - Gastroenterology Research Center
The Israelitisches Krankenhaus Hamburg is actively engaged in advancing therapeutic approaches for complex gastrointestinal motility disorders. The center specializes in clinical research focused on gastroparesis, a debilitating condition characterized by delayed stomach emptying that significantly impacts patient quality of life.
- Idiopathic and diabetic gastroparesis treatment optimization
- Novel prokinetic agent evaluation and dose-finding studies
- Gastrointestinal motility disorders clinical management
The research team demonstrates particular expertise in evaluating innovative pharmacological interventions for patients suffering from moderate to severe gastroparesis. Their clinical trial portfolio includes comprehensive efficacy and safety assessments of emerging therapies designed to address disease signs and symptoms, contributing valuable data to support evidence-based treatment strategies for both idiopathic and diabetic gastroparesis patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Israelitisches Krankenhaus Hamburg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Naronapride Dihydrochloride Trihydrate in Moderate Idiopathic or Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Study | Dr. Falk Pharma GmbH | Phase II | Not Recruiting | Jan 2023 | Jun 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Naronapride Dihydrochloride Trihydrate | 1 | Unknown | 2023-01-03 | 2023-01-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.